000 01046 a2200289 4500
005 20250516184307.0
264 0 _c20150511
008 201505s 0 0 eng d
022 _a1600-0641
024 7 _a10.1016/j.jhep.2013.11.032
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCoilly, Audrey
245 0 0 _aReply to: "Frequent plasma cell hepatitis during telaprevir-based triple therapy for hepatitis C after liver transplantation".
_h[electronic resource]
260 _bJournal of hepatology
_cApr 2014
300 _a896-7 p.
_bdigital
500 _aPublication Type: Letter; Comment
650 0 4 _aFemale
650 0 4 _aHepatitis C, Chronic
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aLiver Transplantation
650 0 4 _aMale
650 0 4 _aProtease Inhibitors
_xtherapeutic use
700 1 _aSebagh, Mylène
700 1 _aDuclos-Vallée, Jean-Charles
773 0 _tJournal of hepatology
_gvol. 60
_gno. 4
_gp. 896-7
856 4 0 _uhttps://doi.org/10.1016/j.jhep.2013.11.032
_zAvailable from publisher's website
999 _c23346198
_d23346198